BlackRock Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $17K | Hold |
1,315
| – | – | ﹤0.01% | 3416 |
|
|
2016
Q3 | $24K | Hold |
1,315
| – | – | ﹤0.01% | 3344 |
|
|
2016
Q2 | $14K | Sell |
1,315
-2,493
| -65% | -$26.5K | ﹤0.01% | 3465 |
|
|
2016
Q1 | $72K | Buy |
3,808
+511
| +15% | +$9.66K | ﹤0.01% | 3008 |
|
|
2015
Q4 | $88K | Sell |
3,297
-1,729
| -34% | -$46.1K | ﹤0.01% | 2937 |
|
|
2015
Q3 | $229K | Sell |
5,026
-288
| -5% | -$13.1K | ﹤0.01% | 2613 |
|
|
2015
Q2 | $171K | Buy |
5,314
+15
| +0.3% | +$483 | ﹤0.01% | 2842 |
|
|
2015
Q1 | $169K | Buy |
5,299
+867
| +20% | +$27.7K | ﹤0.01% | 2746 |
|
|
2014
Q4 | $168K | Sell |
4,432
-230
| -5% | -$8.72K | ﹤0.01% | 2709 |
|
|
2014
Q3 | $123K | Sell |
4,662
-115
| -2% | -$3.03K | ﹤0.01% | 2863 |
|
|
2014
Q2 | $141K | Buy |
4,777
+331
| +7% | +$9.77K | ﹤0.01% | 2821 |
|
|
2014
Q1 | $165K | Buy |
4,446
+381
| +9% | +$14.1K | ﹤0.01% | 2745 |
|
|
2013
Q4 | $168K | Buy |
4,065
+313
| +8% | +$12.9K | ﹤0.01% | 2734 |
|
|
2013
Q3 | $199K | Buy |
3,752
+44
| +1% | +$2.33K | ﹤0.01% | 2542 |
|
|
2013
Q2 | $198K | Buy |
+3,708
| New | +$198K | ﹤0.01% | 2465 |
|